France uses Medication Shield technology as part of COVID-19

France uses Medication Shield technology as part of COVID-19 vaccination campaign


Share
French medication intelligence company Synapse Medicine has rolled-out its Medication Shield technology in collaboration with the regional pharmacovigilance centers (CRPVs) and the French National Agency for Medicines and Health Products Safety (ANSM).
The technology claims to increase the safety of the COVID-19 vaccination campaign in France by managing the adverse drug reactions (ADRs) signals on a reporting portal, which is implemented by the French Ministry of Health.
The reactions are encoded automatically into a standardised international terminology (MedDRA) which ranks them by severity.
Synapse Medicine has been working in collaboration with the health institutions for the last 18 months on the management of pharmacovigilance cases. They have since published an infographic explaining how the Medication Shield technology is integrated into the French pharmacovigilance system.  

Related Keywords

United Kingdom , France , French , , Pfizer , Health Products Safety , Astrazeneca , French National Agency For Medicines , French Ministry Of Health , Synapse Medicine , Medication Shield , French National Agency , French Ministry , Genpact United Kingdom , ஒன்றுபட்டது கிஂக்டம் , பிரான்ஸ் , பிரஞ்சு , ஃபைசர் , ஆரோக்கியம் ப்ராடக்ட்ஸ் பாதுகாப்பு , பிரஞ்சு அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஒத்திசைவு மருந்து , மருந்து கவசம் , பிரஞ்சு அமைச்சகம் , கென்பக்த் ஒன்றுபட்டது கிஂக்டம் ,

© 2025 Vimarsana